Page 22 - 2023 Taiwan Health and Welfare Report

02 2023 Taiwan Health and Welfare Report 02

Table 2-1 Incidence of Ten Leading Cancers, 2020

Male Female
Age- Age-
Standardized Standardized
No. of Incidence No. of Incidence
Rank Cancer Site Rank Cancer Site
Cases Rate Cases Rate
(Per 100,000 (Per 100,000
Population) Population)
1 Colon, rectum and anus 9,477 48.6 1 Female Breast 15,259 82.1
Lungs, Trachea, and Lungs, Trachea, and
2 8,877 44.7 2 7,493 34.6
Bronchus Bronchus
Oral Cavity, Opharynx,
3 7,474 40.9 3 Colon, rectum and anus 7,352 33.3
and Hypopharyn
Liver and Intrahepatic
4 7,617 39.1 4 Thyroid Gland 3,715 23.5
Bile Ducts
5 Prostate Gland 7,178 34.9 5 Uterus 3,032 16.3
Liver and Intrahepatic
6 Esophagus 2,668 14.2 6 3,365 14.3
Bile Ducts
2,464 12.3 Ovary, Fallopian Tube,
7 Stomach 7 1,824 10.7
(2,114) (10.5) and Broad Ligament
1,793 7.9
8 Skin 2,324 11.5 8 Stomach
(1,408) (6.1)
9 Leukemia 1,549 9.9 9 Skin 1,908 7.8
Non-Hodgkin
10 1,719 9.5 10 Cervix 1,436 7.8
lymphoma (NHL)
Total 63,893 336.2 Total 58,086 292.8
Source: Department of Health Promotion Administration, MOHW, R.O.C. (Taiwan)
Notes: 1. Cancer registry data excludes carcinoma in situ.
2. Ranked from highest to lowest by age-standardized incidence rate (per 100,000 population).
3. The age-standardized incidence rate is based on the standard world population age structure in 2000. Formula: Σ(Age-Specific
Incidence Rate x Standard Age-Specific Population)/Standard Total Population.
4. Cases of gastrointestinal stromal tumors (GIST) associated with gastric cancer have been considered as malignant tumor reports
since the diagnosis year 2020 (including High Risk GIST only before the diagnosis year 2019 required reporting). Hence, the
number of cases and standardized incidence rates for gastric cancer in the parentheses below do not include GIST cases.

2. Causes of Cancer Death
In 2022, there were 51,927 deaths due to malignant The ten leading causes of cancer death in 2022
neoplasms accounting for 24.9% of total deaths were cancers of the (1) trachea, bronchus and lung;
and a crude mortality rate of 222.7 per 100,000 (2) liver and intrahepatic bile ducts; (3) colon, rectum
population. This represented an increase of 1.2% and anus; (4) breast (female); (5) prostate; (6) oral
compared to the previous year and an increase of cavity; (7) pancreas; (8) stomach; (9) oesophagus;
17.4% compared to 2012. The standardized cancer (10) ovary. Compared to 2012, cancers of the
mortality rate in 2022 was 116.0 per 100,000 prostrate, pancreas, and ovary rose in the rankings,
population, a decrease of 1.8% compared to 2021 while cancers of the oral cavity, stomach and
and a decrease of 12.6% compared to 2012. oesophagus fell. (Figure 2-7).

20 21